This company has nothing in a P3 trial except for failures. Many P2's but no real randomized data just lots of promise ( 15 years of promise), ODD is just more smoke to try and delay/prevent the coming delisting. Steer clear of this company IMO; better buys are BMY, AMGN (Oncolytic virus that works in P3) GILD and for speculation RNN.
I wrote my loss off on this turd and bought RNN, AMGN and GILD. Never looked back - this company has the right idea but the wrong science and management IMO. Oncolytic viruses are a part of the future but need to be modified to improve efficacy - watch other companies including AMGN that have a modified virus with P3 data awaiting approval.